» Articles » PMID: 26943652

Selective Expression of Transthyretin in Subtypes of Lung Cancer

Overview
Journal J Mol Histol
Specialty Biochemistry
Date 2016 Mar 5
PMID 26943652
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Transthyretin (TTR) is expressed primarily in liver, choroid plexus of brain and pancreatic islet A and B cells. It is also synthesized in some endocrine tumors. In the present study, the protein expression of TTR in lung cancer tissues and cell lines was investigated by western blot. The mRNA expression of TTR in 24 pairs of frozen lung cancer tissues was examined by RT-PCR. The specific expression and cellular distribution of TTR were also evaluated in 104 paraffin-embedded lung cancer samples and 3 normal lung tissues by immunohistochemistry. Similarly, the subcellular localization and expression of TTR were further analyzed in lung cancer cell lines. With the exception of mucinous adenocarcinoma, the expression of TTR protein was observed in all tested subtypes of lung carcinoma. Adenocarcinoma displayed the highest positive expression rate of TTR, accounting for 84.4 %, and the positive expression rate of TTR was up to 85.7 % at stages III and IV. The secretory bubbles with strong TTR staining were observed in luminal cells of lung cancer. Furthermore, the localization of TTR in the cytoplasm of lung cancer cells and the secretion of TTR into extracellular milieu were also confirmed. Taken together, TTR is selectively synthesized in lung cancer cells and can be secreted extracellularly.

Citing Articles

The impact of inflammation and acute phase activation in cancer cachexia.

Robinson T, Hamidi T, Counts B, Guttridge D, Ostrowski M, Zimmers T Front Immunol. 2023; 14:1207746.

PMID: 38022578 PMC: 10644737. DOI: 10.3389/fimmu.2023.1207746.


Information-incorporated sparse convex clustering for disease subtyping.

Zhang X, Liu C Bioinformatics. 2023; 39(7).

PMID: 37382570 PMC: 10329496. DOI: 10.1093/bioinformatics/btad417.


Quantification of promoting efficiency and reducing toxicity of Traditional Chinese Medicine: A case study of the combination of hook. f. and hance in the treatment of lung cancer.

Zhang X, Wang K, Dai H, Cai J, Liu Y, Yin C Front Pharmacol. 2022; 13:1018273.

PMID: 36339610 PMC: 9631451. DOI: 10.3389/fphar.2022.1018273.


The role of transthyretin in cell biology: impact on human pathophysiology.

Magalhaes J, Eira J, Liz M Cell Mol Life Sci. 2021; 78(17-18):6105-6117.

PMID: 34297165 PMC: 11073172. DOI: 10.1007/s00018-021-03899-3.


Effect and Mechanism of Transthyretin over-Expression on Proliferation and Cell Cycle of Lung Cancer A549 Cells.

Zhu D, Li X, Gong H, Li J, Lu X, Xia H Iran J Public Health. 2021; 50(4):710-720.

PMID: 34183920 PMC: 8219626. DOI: 10.18502/ijph.v50i4.5995.


References
1.
Jacobsson B, Collins V, Grimelius L, Pettersson T, Sandstedt B, Carlstrom A . Transthyretin immunoreactivity in human and porcine liver, choroid plexus, and pancreatic islets. J Histochem Cytochem. 1989; 37(1):31-7. DOI: 10.1177/37.1.2642294. View

2.
Guo D, Hu K, Lei Y, Wang Y, Ma T, He D . Identification and characterization of a novel cytoplasm protein ICF45 that is involved in cell cycle regulation. J Biol Chem. 2004; 279(51):53498-505. DOI: 10.1074/jbc.M406737200. View

3.
Chen J, Chen L, Xia Y, Zhou H, Yang R, Wu W . Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma. J Cancer Res Clin Oncol. 2013; 139(7):1117-27. DOI: 10.1007/s00432-013-1422-4. View

4.
Geho D, Liotta L, Petricoin E, Zhao W, Araujo R . The amplified peptidome: the new treasure chest of candidate biomarkers. Curr Opin Chem Biol. 2006; 10(1):50-5. DOI: 10.1016/j.cbpa.2006.01.008. View

5.
Ang L, Debowski T, Michalski R . Immunolocalization of prealbumin (transthyretin) in renal cell carcinoma. Histopathology. 1991; 18(6):565-8. DOI: 10.1111/j.1365-2559.1991.tb01487.x. View